PerkinElmer appoints Payal Agrawaal as MD - India & South Asia
Pfizer strengthens AI collaboration with XtalPi to accelerate drug discovery
Moderna announces promising efficacy results from mRNA flu vaccine trial
Bemarituzumab Plus chemo improves overall survival in FGFR2b+ gastric cancer
Fredun Pharmaceuticals acquires One Pet Stop to foray into pet care market
Biocon Biologics expands insulin access in Malaysia
Torrent Pharma to acquire KKR’s stake in JB Pharma for Rs. 25,689 Cr
Zambon launches intravenous formulation of Fluimucil
Sartorius expands manufacturing and R&D capacities for bioprocess solutions in France
Alembic announces USFDA final approval for single-dose vials
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1751371539)
.jpg?v=1751371539)
